Introduction
Tungstate heteropolyanions (HPA) belong to a family of polyoxotungstates of a cryptate structure with an alkaline or alkaline-earth cation in the central cage and negative charges on all oxygen atoms (Fisher et al., 1976) . Systematic examination of the HPA compounds revealed that ammonium 21-tungsto-9-antimonite [HPA-23: (NH4)17Na-(NaSbgW21086)] shows potent antiviral activity against various RNA and DNA viruses, particularly retroviruses (Jasmin et aI., 1973 (Jasmin et aI., , 1974 Fisher etal., 1976; Liderau et al., 1978) . Recently, Yamase's group (Inoue et al., 1990; Take et aI., 1991; Fukuma et al., 1991) reported that a polyoxotungstate with Keggin-type structure on PM-19 (K7(PTi2W1004ol.6H20), was a more potent inhibitor of human immunodeficiency virus type 1 (HIV-1) than the 'non-Keggin' compound HPA-23. Moreover, the compound also proved active against herpes simplex virus type 1 (HSV-1). The authors suggested that this com-. pound interfered with an early step of virus replication such as virus adsorption and/or virus penetration. Hill et al. (1990) reported that certain silicon-containing polyoxometalates were more potent and selective anti-HIV compounds than HPA-23. We have now synthesized a novel series of silicon-containing polyoxotungstates containing either the 'Keggin' or 'Keggin sandwich' structure (Table 1; Fig. 1 ), and investigated their activities against enveloped viruses such as orthomyxo (influenza A, influenza B), paramyxo [respiratory syncytial virus (RSV), parainfluenza virus type 3], herpes [HSV-1, thymidine kinase-deficient (TK-) HSV-1, HSV-2, human cytomegalovirus (HCMV)] and retroviruses (HIV-1, HIV-2).
Results

Activity against orthomyxoviruses and paramyxoviruses
The polyoxosilicotungstates were evaluated for their inhibitory effects on the cytopathicity of orthomyxoviruses in MOCK cells ( Table 2 ). The Keggin structure compounds inhibited influenza virus A replication at a 50% JM1490  20  >200  20  >200  JM1491  27  200  20  >200  JM1493  20  100  20  200  JM1496  27  >100  30  >100  JM1731~100  100  60  >100  JM2764  27  20  20  >200  JM2767  20  60  20  200  JM2815  60 The polyoxosilicotungstates were also evaluated for their inhibitory effects on the replication of the pararnyxoviruses RSV and parainfluenza virus type 3. All test.cornpounds were found to be moderately active against RSV (Table 2) . JM2815 (Keggin type) proved the most potent with an IG so value of 8.0 Ilg rnr'. None of the polyoxosilicotungstates was active against parainfluenza virus type 3. The sulphated polysaccharide dextran sulphate that was included as a positive control showed a similar activity spectrum as the polyoxosilicotungstates, l.e, activity against influenza A and RSV but not influenza B or parainfluenza type 3.
Activity against herpesviruses
When the polyoxosilicotungstates were evaluated for their inhibitory effect on the cytopathicity of HSV (type 1 and type 2 and a TK-deficient mutant) in EsSM cells, all compounds, except for the cyclam salt, compound JM1731, showed antiviral activity (Table 3) . As a rule, the polyoxotungstates were found to inhibit HGMV replication more efficiently than HSV replication. All compounds inhibited HGMV replication with IG so values that were a Fifty per cent inhibitory concentration, based on the inhibition of the cytopathicity of influenza A virus (Ishikawa) or influenza B virus (Singapore) in MDCK cells, or RSV (Long) in HeLa cells, or parainfluenza virus type 3 (VR-93) in Vero cells. comparable or slightly higher than that of dextran sulphate.
Activity against retroviruses
When examined for their inhibitory effects on the cytopathicity of the human immunodeficiency viruses HIV-1 and HIV-2 in MT-4 cells, the test compounds showed 50% antivirally effective concentrations ranging from 0.2 JJ.g mr 1 (JM1590) to 10 JJ.g ml-1 (JM1731) ( Table 4) .
Cytotoxicity of polyoxosiiico tungstates
No microscopically detectable alteration of normal cell morphology was noted with any of the compounds at concentrations that were 20-to 1000-fold higher than their IC so for virus replication ( Table 5 ). The compounds inhibited MT-4 cell proliferation by 50% at concentrations ranging from 42JJ.gml-1 (HPA-23) to >1000JJ.gmr 1 (JM2815, JM1731, JM2820).
Influence of time of addition on the antiviral activity of polyoxosilicotungstates
The inhibitory effects of polyoxosilicotungstates (JM1493, JM1813 and JM2820) on influenza A virus, RSV, HSV-1 b Cytotoxic concentration, or concentration required to reduce cell growth by 50% as determined by the MIT method. Total cell number of (untreated) control cells was 1 x 10 6 0.2 rnr" well-' (this is a 33fold increase in cell number compared to day 0) after a 5 day incubation period.
Polyoxosilicotungstates inhibit the association of radiolabelled HCMV particles with HEL cells
The polyoxosilicotungstates were evaluated for their inhibitory effect on the association of [methyI-3H] dThdlabelled CMV particles with HEL cells (Fig.2) . At a concentration of 8119ml-1 JM1493, JM1813 and JM2820, reduced" cell-associated radioactivity by 83 to 95%. The IC so values were 1.0, 1.6, and 2.3 I1g ml-1 for JM1493, JM1813, and JM2820, respectively. This is close to the IC so values of these compounds for inhibition of viral cytopathicity (Tables 3 and 6 ). Dextran sulphate that was included as a reference compound, inhibited ceIl-associated radioactivity by 50% at a concentrationof 0.9 I1g mr" .
os 1493 1813 :iand HCM\( were determined following addition of the test compounds at different times (Table 6 ). When present. during the 1-h virus adsorption period, the test compounds were effective in inhibiting the replication of RSV, HSV-1, and HCMV but not influenza A virus. When the compounds were added after the virus adsorption period, they were still effective in suppressing the replication of influenza A and RSV (IC so : 10-35 I1g rnl") but not HSV-1 or HCMV (IC so : >100I1gml-1). These data suggest that the compounds interfere with the virus-cell binding process (HCMV and HSV-1), virus-cell fusion process (influenza A) and/or both processes (RSV).
Binding of polyoxosilicotungstates to HCMV particles
The binding capacity of polyoxosilicotungstates to HCMV particles was determined by heparin-sepharose affinity chromatography. Radiolabelled HCMV particles that were applied onto a heparin-sepharose column remained attached, whereas most of the virus passed through a control sepharose column (Fig.3) . Inclusion of dextran sulphate (MW 5000), JM2820, JM1493 or JM1813 at 100l1gml-1 in the elution buffer resulted in displacement of the heparin-bound radiolabelled virions from the column.
Discussion
In the present study we demonstrated that silicon-containing polyoxotungstates possess activity against influenza A, RSV, HSV-1, TK-HSV-1, HSV-2, HCMV, HIV-1 and HIV-2, but not influenza B or parainfluenza 3, when present during or after the virus adsorption. The 'Keggin-type' compounds are generally formulated as [xn+M12040](s-nl-in which M is Mo(VI) or W(VI); X = B(III), Si(IV), Ge(IV), Ti(IV), Zr(IV), As(V) or P(V). In JM1493 (H4SiW12040), the central (hetero) atom is silicon and the metal is tungsten. One tungsten atom in JM1493 was replaced with an aquated metal ion or an organometallic fragment to form ternary heteropolyoxotungstates (JM1490, JM1491, JM1496, JM2767,JM2815 and JM2764 in Table 1 ) (Pope, 1983) . These 'Keggin' compounds inhibited the replication of influenza A, RSV, HSV-1, TI<-HSV-1, HSV-2, HCMV, HIV-1 and HIV-2 with approximately the same potency as the parent compound JM1493. However, all compounds, except for JM2815 and JM2764, proved somewhat more toxic to the host cells than the JM1493. In terms of selectivity, JM2815 proved superior to JM1493 against HIV-1 (>106), HIV-2 (>1010) and RSV (>125) ( Table 7) . Among the 'Keggin sandwich' compounds (two Keggin structures combined via one or more metal ions: JM1590, JM1813, JM1814, JM1815), JM1590 was the most potent inhibitor of HIV-1 and HIV-2 (IC so: 0.2 and O.4llg mr", respectively; selectivity index: 1150 and 575, respec- f--n tively). Furthermore, all 'Keggin sandwich' compounds showed stronger activity against herpes simplex virus than the parent 'Keggin' compound JM1493, although the activity of the 'Keggin' and 'Keggin-sandwich' compounds against orthomyxoviruses (influenza A) and paramyxoviruses (RSV) proved comparable. In attempts to increase the antiviral potency of the polyoxometalates, we combined the 'Keggin' molecule (JM1493) with two cyclam molecules, resulting in a cyclam Keggin salt (JM1731: (cyclaml2[SiW 1204o] ). The anti-HIV activity of the hybrid molecule proved comparable to that of the parent compound JM1493. JM1731 was devoid of anti-HSV and anti-influenza virus activity. JM2820 ([MesNH]s[SiNbeW1s0n]), which can be regarded as a 'double Keggin' molecule, proved particularly active against TK-HSV-1, HSV-2, HCMV, HIV-1, and HIV-2 with selectivity indices of 118, >500, >333, >163 and>191, respectively.
Sulphated polysaccharides such as heparin, dextran sulphate, pentosan polysulphate and polyhydroxycarboxylates derived from phenolic compounds, as well as polycarboxylates based on aurintricarboxylic acid, represent other classes of polyanionic compounds, which have been accredited with in vitro activity against various RNA and DNA viruses (Ito et sl., 1987 (Ito et sl., , 1989 Baba et a/., 1988a Baba et a/., , 1988b Mitsuya et a/., 1988; Schols et a/., 1989 Schols et a/., , 1990a Schols et a/., , 1991 Neyts et a/., 1992a Neyts et a/., , 1992b . Their mechanism of action has been attributed to an inhibition of virus adsorption to the cell membrane. Schols et at. (1990b Schols et at. ( , 1991 found a close correlation between the anti-HIV activity of these polyanionic compounds and their inhibitory effects on anti-gp120 mAb binding. They also demonstrated that sulphated polymers exhibit their anti-HIV activity by binding to the principal neutralizing domain (Vsloop) of gp120. For HSV and HCMV it was shown that polyanionic compounds (such as heparin and dextran sulphate) interact with viral envelope glycoproteins that are necessary for attachment of the virus particles to cell surface heparan sulphate, which is the initial binding site of these viruses at the cell surface (WuDunn and Spear, 1989; Herold et a/., 1991; Neyts et a/., 1992a; Kari and Gerhz, 1992) . Take et at. (1991) suggested that the 'Keggin' type polyoxotungstate PM-19 [K7(PTi2W1004o) .6H20] inhibits HIV-1 replication through interfering with the first step of the virus replication cycle, i.e. virus adsorption. Recently, we have demonstrated that polyoxometalates inhibit HIV-1 replication through blocking the binding of HIV-1 virions to the outer cell membrane (Yamamoto et a/., 1992) . The broad antiviral activity spectrum of the polyoxosilicotungstates, encompassing other enveloped RNA and DNA viruse~in addition to HIV (such as influenza A virus, RSV, HSV-1, HSV-2 and HCMV), may be based on (1) inhibition of virion (HSV, HCMV and HIV) binding to the host cells, (2) inhibition of virus-cell fusion (Hosoya et el., 1991) . The inhibitory effect of the polyoxotungstates on the binding of HSV, HCMV, and HIV to the cell surface is evident from the facts that (1) the compounds are ineffective if added after the viral adsorption period and that (2) they inhibit the binding of radiolabelled HCMV to the cell surface. We also demonstrated that polyoxometalates, like sulphated polymers, are able to displace HCMV particles that are bound to a heparin-sepharose matrix. It may be assumed that the polyoxometalates are able to compete with heparan sulphate for binding to those sites of the viral envelope that are required for interaction with the cell surface heparan sulphate. Hosoya et al. (1991) demonstrated that paramyxoviruses (RSV) and orthomyxoviruses (influenza A virus) that have the tripeptide sequence (Phe-Leu-Gly) in their F 1 or HA glycoprotein are sensitive to dextran sulphate and other polyanionic compounds; whereas parainfluenza virus type 3, influena B virus and measles virus that do not possess this amino acid sequence are not sensitive to the polyanionic compounds. The sulphated polymers are thought to interact with the virus-cell fusion process (influenza A virus) or both virus-cell binding and fusion (R8V). Since the activity spectrum of the polyoxosilicotungstates against paramyxo-and orthomyxoviruses is comparable to the activity spectrum of sulphated polymers, one may assume that polyoxosilicotungstates and sulphated polymers act via a similar mechanism of action.
In conclusion, silicon-containing polyoxotungstates were found to exert a selective inhibitory effect on several enveloped human viruses. The compounds inhibit an early step in the virus replicative cycle [virus adsorption to the host cells (HSV, HIV, HCMV), virus cell-fusion (influenza A virus), or both (RSV)].
Materials and Experimental procedures
Compounds
The polyoxosilicotungstates were synthesized according to the procedures that havebeendescribed elsewhere (Yamamoto et al., 1992) . They belong to the 'Keggin' or 'Keggin sandwich' type (Table 1) . HPA-23 and dextran sulphate (MW 5.000 : Sigma) were included as reference compounds. All compounds, exceptfor JM1731 that was dissolved in DMSO, were dissolved in phosphate-buffered saline (PBS) at 20 mgmr' .
Viruses
The virus stocks were prepared as described previously : influenza A virus (strain Ishikawa/7/82(H 3N2 »and influenza B virus (strain Singapore/222/79) (Shigeta et aI., 1988) ; RSV (strain Long) (Kawana et al., 1987) ; parainfluenza virus type 3 (strain VR-93) (De Clercq, 1985) ; HSV-1 (strain KOS), HSV-2 (strain G) and HSV-1 TK-(strain Field C/37/101) (De Clercq et al., 1980) ; HCMV (strain Davis) ; HIV-1 (strain HTLV-lIls1LAI) and HIV-2 (strain LAV-2 ROD) (Pauwels et al., 1988) . HIV-1 and HIV-2 were prepared from the culture supernatants of HIV-1-or HIV-2-infected cell lines (HUT-78/HTLV-IIIB and MT4/LAV-2 ROD, respectively).
Celfs
The cell lines used for the antiviral assays were : MOCK (Madin-Darby canine kidney) epithelial cells, Vero (an epithelial cell line derived from African green monkey), HeLa (a human epithelial cell line derived from a cervix carcinoma), E 6SM (human embryonic skin muscle) fibroblast, and MT-4 (a human T-cell line established by cocultivation of normal human cord blood leucocytes with leucocytes from an adult T-cell leukaemia patient). The cells were cultivated in Eagle's minimum essential medium (MEM) (Gibco) supplemented with 3 mM glutamine, 0.07% bicarbonate and 10% fetal calf serum, except for MT-4 cells which were cultivated in RPMI-1640 medium (Gibco).
Antiviral activity assays
Inhibition of virus-induced cytopathicity was measured following well-established procedures (De Clercq et al., 1980; De Clercq, 1985) . For HIV-1 and HIV-2, the procedure of Pauwels et al. (1988) was followed: MT-4 cells were brought into microtitre tray wells containing various concentrations of the test compounds. The cells were infected with HIV-1 or HIV-2 at 100 CCID so per well. After 5 days incubation at 37°C, virusinduced cytopathicity was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTI) method (Pauwels et al., 1988) . For the other viruses, confluent (MOCK, HeLa, Vero or E 6SM) cell cultures in 96-well microtitre trays were inoculated with virus at 100 CCID so (or with 100 plaque forming units of HCMV) per well in the presence of various concentrations of the test compounds. The cell cultures were further incubated at 35°C (for influenza A or B virus, RSV or parainfluenza type 3) or 37°C (for HSV-1, HSV-1 TK-, HSV-2 or HCMV), and virus-induced cytopathicity was monitored microscopically, as described previously (De Clercq et el., 1980; De Clercq, 1985; Kawana et al., 1987; Shigeta et al., 1988; Neyts et al., 1990) . The concentration required to reduce virus-induced cytopathicity by 50% was estimated as the 50% inhibitory concentration (IC so ). The experiments were carried out two or more times and mean values are provided for the ICso·
Influence of time of addition on the antiviral activity of polyoxosilicotungstates
Cells were incubated with 0.1 ml of maintenance medium with or without the test compounds and 0.1 ml of virus suspension containing 100 CCID so [or 100 p.f.u. (HCMV)J. After 1 h incubation at 35°C (for myxoviruses) or 37°C (for herpesviruses), medium containing unadsorbed virus was removed, and the cultures were washed twice with MEM. Then, 0.2 ml of mainte-nance medium without or with the test compounds were added to the cell cultures. After 3 days (for HSV), 5 days (for myxoviruses) or 7 days (HCMV) of incubation, the IC so values were determined.
Binding of radiolabelfed CMV to HEL celfs
The method for monitoring binding of radiolabelled CMV particles to the cells has been described previously (Neyts et et., 1992a (Neyts et et., , 1992b . Briefly, confluent HEL cell cultures in 96-well plates were incubated with the test compounds at concentrations of 40,8, 1.6 and 0.3 Ilg rnl " for 1-5 min at room temperature. The virus suspension (>10 8 p.f.u. 10--6 cpm rnr')was added to the cell cultures for an additional 60 min at 37°C. Then, the cells were washed 4 times with PBS, and cell-associated radioactivity was determined.
Affinity chromatography
One-millilitre columns of heparin-sepharose CL-6B or Sepharose 6B (Pharmacia) were equilibrated with PBS, and 200 III of a solution of dextran sulphate (100 Ilg mt") or polyoxometalates (100 Ilg rnr") in MEM were applied onto the columns. Then, the radioactive virus suspension (-28000 c.p.m.) was applied onto the columns, followed by 1.2 ml MEM (control) or 1.2 ml of the test compound solution. The eluent was collected and spotted onto GF/C filters (Whatman). The filters were washed 3 times with 10% trichloroacetic acid (TCA) and were then assayed for radioactivity (Neyts et al., 1992a (Neyts et al., , 1992b .
Cytotoxicity assay
The concentration required to cause a microscopically detectable alteration of normal cell morphology was estimated as the minimum cytotoxic concentration (MCC). Inhibition of MT-4 cell growth was determined by the MTI method as described previously (Pauwels et al., 1988) .
